Comparison Chart Tempest Therapeutics, Inc.
Stocks
TPST
US87978U2078
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.6001 USD | -3.86% |
|
-19.20% | -79.09% |
| 10-14 | Tempest Therapeutics, Inc. Announces Appointment of John W. Frederick as Director | CI |
| 10-07 | Sensorion: Louis J. Arcudi III appointed chief financial officer |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -3.86% | -19.20% | -79.09% | -94.08% | -99.67% | 9.93M |  | | |
- Stock Market
- Stocks
- TPST Stock
- Charts Tempest Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
